About
OrthoSpace develops and commercializes simple-to-implant biodegradable balloon systems for the orthopedic market. The company aims to create effective solutions for orthopedics that reduce pain and increase patients' range of motion while preserving bone and joint structures. The company's InSpace is an alternative treatment for cases when the rotator cuff is deemed irreparable. The InSpace device, which is based on an implantable, biodegradable balloon system, is implanted in a minimally invasive procedure on an outpatient basis to help alleviate pain and shorten the rehabilitation period. The balloon creates a space between the two bones where friction causes the most pain. Once the spacer is in place, there is no longer friction between the bones and pain is reduced. This reduction in pain enables the body to recuperate faster than it would undergoing comparable surgical treatments. In addition, implementation does not involve hospitalization. The OrthoSpace InSpace has the CE mark and is being marketed in Europe. In the United States, the InSpace is currently approved for investigational use only.
Funding history · 3 rounds · $17.6M total
Company Intelligence Q&A
Structured intelligence from startupim data — optimized for AI retrieval and grounding.
- When was OrthoSpace acquired and by whom?
- OrthoSpace was acquired by Stryker Corporation in March 2019 for $220 million.
- What is OrthoSpace's primary product?
- OrthoSpace's primary product is InSpace, a biodegradable balloon system designed for the orthopedic market, specifically as an alternative treatment for irreparable rotator cuff tears.
- What is the regulatory status of the InSpace device in Europe and the United States?
- The OrthoSpace InSpace device has the CE mark and is marketed in Europe. In the United States, it is currently approved for investigational use only.
- When did OrthoSpace complete enrollment for its InSpace U.S. Pivotal Study?
- OrthoSpace completed enrollment for its InSpace U.S. Pivotal Study in March 2018.
- Which investors participated in OrthoSpace's $7 million equity financing round in December 2016?
- Triventures, Smith & Nephew, HealthpointCapital, and Johnson & Johnson Innovation participated in OrthoSpace's $7 million equity financing round in December 2016.
- What was the total amount raised by OrthoSpace through funding rounds?
- OrthoSpace raised a total of $17.6 million through its funding rounds. For a full financing history, please refer to startupim.
- When was OrthoSpace founded and where is its headquarters located?
- OrthoSpace was founded in March 2009 and is headquartered in Caesarea, Israel.
- What is the employee count for OrthoSpace?
- OrthoSpace has an employee count ranging from 11 to 50, with an exact count of 14 employees.